GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Male breast and prostate cancer need equal awareness. Know symptoms, risks, and why early detection and regular screening are ...

The former president addressed an audience in Boston on Sunday night after receiving the Lifetime Achievement Award from the ...

GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...

Former President Joe Biden called these "dark days" as he urged Americans to stay optimistic and not to check out in response ...

Biotech insiders tout antibody-drug conjugates as the next big thing in cancer treatment, with firms urged to pursue global ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

Recovering from cancer, former President Joe Biden warned of “dark days” under Donald Trump, urging Americans to defend ...

Gerhardt Attard, M.D., Ph.D., from University College London, and colleagues conducted a double-blind trial that evaluated combining niraparib with AAP versus placebo and AAP in mCSPC with HRR gene ...

A suspected DUI driver crashed into a firetruck in Puyallup while firefighters battled a garage fire, raising safety concerns ...